Journal article

The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years

AB Spurdle, JL Hopper, XQ Chen, GS Dite, JS Cui, MRE McCredie, GG Giles, S Ellis-Steinborner, DJ Venter, B Newman, MC Southey, G Chenevix-Trench

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | AMER ASSOC CANCER RESEARCH | Published : 2002

Abstract

The BRCA2 N372H nonconservative amino acid substitution polymorphism appears to affect fetal survival in a sex-dependent manner, and the HH genotype was found to be associated with a 1.3-fold risk of breast cancer from pooling five case-control studies of Northern European women. We investigated whether the BRCA2 N372H polymorphism was associated with breast cancer in Australian women using a population-based case-control design. The BRCA2 372 genotype was determined in 1397 cases under the age of 60 years at diagnosis of a first primary breast cancer and in 775 population-sampled controls frequency matched for age. Case-control analyses and comparisons of genotype distributions were conduct..

View full abstract